Advertisement
Australia markets close in 45 minutes
  • ALL ORDS

    7,803.80
    -95.10 (-1.20%)
     
  • ASX 200

    7,553.20
    -88.90 (-1.16%)
     
  • AUD/USD

    0.6400
    -0.0026 (-0.40%)
     
  • OIL

    84.47
    +1.74 (+2.10%)
     
  • GOLD

    2,397.60
    -0.40 (-0.02%)
     
  • Bitcoin AUD

    97,123.29
    +721.72 (+0.75%)
     
  • CMC Crypto 200

    1,284.80
    +399.26 (+43.77%)
     
  • AUD/EUR

    0.6016
    -0.0015 (-0.24%)
     
  • AUD/NZD

    1.0881
    +0.0006 (+0.05%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,210.06
    -175.81 (-1.07%)
     
  • NIKKEI 225

    37,120.25
    -959.45 (-2.52%)
     

Is It Too Late to Buy Viatris Stock?

Is It Too Late to Buy Viatris Stock?

If you're a fan of stable healthcare companies that have the potential to pay you ever-rising dividends until the cows come home, Viatris (NASDAQ: VTRS) might well become a dream stock. The single most persuasive argument against it being too late to buy Viatris is that the company is just getting started. After all, its life as an independent entity started a mere year ago with the merger of Pfizer's generic drugs business, Upjohn, and Mylan.